Research Paper Volume 13, Issue 6 pp 8975—8988
PARP inhibitors in breast and ovarian cancer with BRCA mutations: a meta-analysis of survival
Figure 3. OS of breast or ovarian cancer patients with BRCAm treated with PARPis.
Figure 3. OS of breast or ovarian cancer patients with BRCAm treated with PARPis.